S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
NYSEARCA:CHNA

Loncar China Biopharma ETF Stock Forecast, Price & News

$31.79
+0.10 (+0.32%)
(As of 12/3/2021 12:00 AM ET)
Add
Today's Range
$31.07
$32.05
50-Day Range
$31.69
$37.64
52-Week Range
$29.49
$49.01
Volume
4,260 shs
Average Volume
4,528 shs
Market Capitalization
$11.13 million
P/E Ratio
N/A
Dividend Yield
0.49%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive CHNA News and Ratings via Email

Sign-up to receive the latest news and ratings for Loncar China Biopharma ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer Exchange Traded Concepts
Fund NameLoncar China Biopharma ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:CHNA
Inception Date8/14/2018
Fund ManagerDenise M. Krisko, Habib Moudachirou
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkLoncar China BioPharma Index
CategorySector
FocusHealth Care
Development LevelEmerging Markets
RegionAsia-Pacific

Fund Statistics

Assets Under Management$11.36 million
Average Daily Volume$4.40 thousand
Discount/Premium-0.77%

ETF Expenses

Management Fee0.79%
Other Expenses0.00%
Total Expenses0.79%
Fee Waiver0.00%
Net Expenses0.79%

Administrator, Advisor and Custodian

AdministratorU.S. Bancorp Fund Services, LLC
AdvisorExchange Traded Concepts, LLC
CustodianU.S. Bank, N.A.
DistributorQuasar Distributors, LLC
Transfer AgentU.S. Bank, N.A.
Trustee
Lead Market MakerGTS

Geographic Exposure of CHNA

Currency Exposure of CHNA

Sector Exposure of CHNA

Industry Exposure of CHNA













Loncar China Biopharma ETF (NYSEARCA:CHNA) Frequently Asked Questions

Is Loncar China Biopharma ETF a good dividend stock?

Loncar China Biopharma ETF pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.49%.

What other stocks do shareholders of Loncar China Biopharma ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Loncar China Biopharma ETF investors own include Brookfield Infrastructure Partners (BIP), PaySign (PAYS), Snap (SNAP), AT&T (T), Advanced Micro Devices (AMD), Align Technology (ALGN), American International Group (AIG), AI Powered Equity ETF (AIEQ), AgeX Therapeutics (AGE) and Aflac (AFL).

What is Loncar China Biopharma ETF's stock symbol?

Loncar China Biopharma ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CHNA."

How do I buy shares of Loncar China Biopharma ETF?

Shares of CHNA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Loncar China Biopharma ETF's stock price today?

One share of CHNA stock can currently be purchased for approximately $31.79.

How much money does Loncar China Biopharma ETF make?

Loncar China Biopharma ETF has a market capitalization of $11.13 million.


This page was last updated on 12/4/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.